# Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

> **NCT05628363** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 28 (actual)

## Conditions studied

- Prostate Cancer
- Cancer of the Prostate

## Interventions

- **DEVICE:** Ethos Varian treatment system
- **RADIATION:** Adaptive stereotactic body radiotherapy
- **DRUG:** Androgen deprivation therapy

## Key facts

- **NCT ID:** NCT05628363
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-01-18
- **Primary completion:** 2025-10-25
- **Final completion:** 2030-07-25
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05628363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05628363, "Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05628363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*